Safety and efficacy of transcatheter aortic valve replacement in intermediate risk patients sets the stage for contemporary trials in lower risk groups
Cardiovasc Diagn Ther
.
2016 Oct;6(5):459-461.
doi: 10.21037/cdt.2016.05.01.
Authors
Shikhar Agarwal
1
,
Samir Kapadia
1
,
E Murat Tuzcu
1
,
Amar Krishnaswamy
1
Affiliation
1
Section of Interventional Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
PMID:
27747170
PMCID:
PMC5059394
DOI:
10.21037/cdt.2016.05.01
No abstract available
Publication types
Editorial